Oschmann, Patrick
Bayreuth Medical Center
3 papers on CoChatORCID 0000-0003-1480-0896
Most cited papers
- Verified
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet
Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling
Cited by 942
- Verified · note
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial
Vermersch, P., Brieva-Ruiz, L., Fox, R. J., Paul, F., Ramio-Torrenta, L., Schwab, M., Moussy, A., Mansfield, C., Hermine, O., Maciejowski, M., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation
Multiple Sclerosis Research StudiesPolyomavirus and related diseases
Cited by 74
- Verified
Mindfulness in persons with mild dementia and their caregivers: Exploring trait rumination as a clinical outcome measure
Keune, P. M., Bernard, F., Meister, R., Keune, J., Springer, R., Arlt, R., Holmerová, I., Auer, S., Oschmann, P., & Hansen, S. (2023) · Mindfulness
Mindfulness and Compassion InterventionsDementia and Cognitive Impairment Research
Cited by 6
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free